MTHFR rs2236242: What Your Genotype Means
The rs2236242 single nucleotide polymorphism is an investigated genetic variant located within folate and metabolic regulatory pathways, cataloged in relation to the methylenetetrahydrofolate reductase (MTHFR) pathway. Research indicates that variations at this locus can influence metabolic efficiency, homocysteine turnover, and susceptibility to complex traits like cardiovascular disease. However, clinical evidence remains limited and heavily influenced by dietary intake and ancestral background.
What each genotype means
Typical risk profile
You carry two copies of the common T allele for rs2236242. In population candidate gene studies—often evaluated within the SERPINA12 (vaspin) genomic locus—this baseline genotype has been evaluated for metabolic traits such as type 2 diabetes and body mass index, though findings remain mixed and evidence for direct clinical impact is limited. Carrying this genotype represents the standard genetic background in many populations.
Carried by approximately 40% to 55% of individuals globally, though frequencies vary across regional ancestries.
Heterozygous carrier
You carry one copy of the A allele and one copy of the T allele for rs2236242. Small association studies have investigated this genotype in relation to circulating vaspin adipokine levels and glycemic or metabolic variability, but evidence across diverse populations is conflicting and inconclusive. This variant does not provide a definitive medical diagnosis, and its overall functional effect remains limited.
Carried by roughly 35% to 45% of individuals across diverse global populations.
Homozygous minor allele
You carry two copies of the minor A allele for rs2236242. Preliminary research in specific regional cohorts has explored associations with altered serum adipokine concentrations and modest protective or susceptibility trends for metabolic phenotypes, but findings have not been replicated consistently in large-scale genome-wide studies. Because evidence is limited and non-diagnostic, it should not be used to guide healthcare decisions.
Carried by approximately 10% to 15% of individuals globally, depending on ancestral background.
Genetic Overview and Molecular Identity
The single nucleotide polymorphism (SNP) designated rs2236242 represents a single-base substitution found within human metabolic gene clusters. Genomic databases record standard alleles at this position alternating between thymine (T) and adenine (A). In biochemical research, variants at this locus are frequently evaluated alongside metabolic enzyme families, including the folate-regulating methylenetetrahydrofolate reductase pathway. A nucleotide substitution at this position can subtly alter transcriptional efficiency, post-transcriptional processing, or amino acid composition, resulting in downstream variations in enzyme kinetics. While well-characterized loci such as C677T (rs1801133) and A1298C (rs1801131) directly dictate baseline MTHFR enzyme thermolability, secondary polymorphisms like rs2236242 represent modifier sites that modulate metabolic flux. Variants in this general genomic vicinity are categorized under trait-associated polymorphisms, reflecting subtle shifts in complex physiologic outcomes rather than monogenic disease causality.
Biological Role: Folate Cycling and Homocysteine
The metabolic network governed by folate metabolism processes dietary folates into 5-methyltetrahydrofolate (5-MTHF), a vital methyl donor necessary for cellular life. This enzymatic process serves as the biochemical bridge between the folate cycle and the methionine cycle. Inside cells, 5-MTHF facilitates the remethylation of homocysteine, a sulfur-containing amino acid derivative, back into essential methionine. When enzyme efficiency within this one-carbon network declines due to genetic polymorphisms or nutrient deficiencies, cellular clearance of homocysteine slows, potentially leading to elevated circulating homocysteine levels (hyperhomocysteinemia). Elevated homocysteine is recognized in vascular biology as a pro-inflammatory marker that can promote endothelial dysfunction and oxidative stress. Modulatory genetic variants in these pathways can therefore impact cellular antioxidant generation, transmethylation reactions, and epigenetic DNA methylation.
Current Scientific Evidence and Clinical Strength
Epidemiological and biochemical studies evaluating rs2236242 associate its genotypes with modest statistical variations in metabolic syndrome markers, lipid homeostasis, and susceptibility to cardiovascular traits. Nevertheless, current scientific consensus rates the evidence strength for rs2236242 as limited. Many association studies report conflicting results across differing geographic cohorts, and observed effect sizes remain small. Large-scale Mendelian randomization studies exploring folate-pathway polymorphisms emphasize that modest changes in intermediate enzyme activity rarely translate directly into predictable clinical disease endpoints on their own. Instead, phenotypic outcomes depend strongly on environmental and dietary factors, such as circulating vitamin B9 (folate) and vitamin B12 levels. Major clinical genetic guidelines, such as those from the American College of Medical Genetics and Genomics (ACMG), do not recommend routine clinical screening for non-pathogenic MTHFR polymorphisms because of this weak predictive utility.
Ancestral Diversity and Allele Distribution
The distribution of alleles for rs2236242 demonstrates notable variation across worldwide human populations cataloged in the 1000 Genomes Project and gnomAD. Globally, the minor allele maintains a frequency of approximately 0.35, though regional cohorts diverge markedly. In European and certain Middle Eastern populations, the ancestral allele is predominantly preserved, while heterozygosity and alternative allele homozygosity appear at varying frequencies in East Asian, South Asian, and African lineages. Regional case-control investigations have noted distinct allele frequencies that influence local baseline risk for metabolic traits. Because evolutionary pressures and ancestral dietary patterns—particularly historical access to leafy greens and folate sources—have influenced one-carbon metabolic genes, individual genotype interpretations must account for the population background from which these statistical associations were derived.
Interpreting Your Results: Actionable Insights
Discovering an alternative allele at rs2236242 on a personal genomics report is not a clinical diagnosis and does not signify an active disease or absolute health risk. Rather, it indicates a common statistical variation in a complex metabolic pathway. Leading health authorities, including the Centers for Disease Control and Prevention (CDC), affirm that individuals carrying functional variants in the folate pathway can still efficiently process all standard dietary folates and supplemental folic acid. A healthy balanced diet rich in leafy greens, legumes, and fortified foods remains the foundational method for maintaining adequate folate levels. Individuals with specific questions regarding homocysteine levels, cardiovascular prevention, or medication interactions should consult a licensed physician or clinical genetic counselor rather than adjusting supplements or medications independently.
How common is this variant?
The global minor allele frequency for rs2236242 is approximately 0.35 across 1000 Genomes and gnomAD datasets, with minor allele distribution varying widely from under 20% to over 40% depending on continental ancestry.
Frequently asked questions
Does having a variant at rs2236242 mean I have an MTHFR enzyme deficiency?
No. The presence of a variant at rs2236242 does not signify severe clinical MTHFR deficiency, which is caused by rare, highly disruptive mutations. Polymorphisms like rs2236242 are common statistical variants with limited clinical impact that only subtly modify metabolic parameters.
Can I still process standard folic acid if I carry this variant?
Yes. Authoritative guidance from the Centers for Disease Control and Prevention (CDC) confirms that individuals with common folate pathway variants can successfully process all dietary folates, including synthetic folic acid from foods and standard supplements.
Should I order a laboratory test for homocysteine based on my genotype?
Genetic test results alone do not justify routine diagnostic blood panels. If you have personal or family risk factors for cardiovascular health issues, discuss with your physician whether standard metabolic or homocysteine testing is appropriate for your overall medical care.
Does rs2236242 predict heart disease or cardiovascular risk?
Scientific evidence linking this specific SNP directly to cardiovascular disease is rated as limited and inconsistent. While population studies observe minor statistical associations with metabolic traits, lifestyle factors, diet, and traditional cardiovascular risk markers have a far greater impact on personal risk.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2236242?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29